See also this year's filing and all EDGAR filings for this company.
PDF Report 0000707511_2023_REGENERX_BIOPHARMACEUTICALS_INC.pdf
Logs
| warning | Similarly named company. Duplicate? | None | {'details': [{'other_company': 'PROVECTUS BIOPHARMACEUTICALS INC.', 'shared_tokens': {'biopharmaceuticals'}}]} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0000707511, REGENERX BIOPHARMACEUTICALS INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 306,919 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 75,258 |
| 4 | LiabilitiesCurrent | 553,673 |
| 5 | LiabilitiesNoncurrent | 1,901,219 |
| 6 | remainder_Liabilities | 1,372,756 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 1,478,752 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 76,761 |
| 12 | remainder_NetIncome | -325,464 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 382,177 |
| 1 | Liabilities | 3,827,648 |
| 2 | Expenses | 1,478,752 |
| 3 | Revenues | 76,761 |
| 4 | StockholdersEquity | -3,445,471 |
| 5 | NetIncome | -1,727,455 |
| 6 | ComprehensiveNetIncome | -1,727,455 |
| 7 | BaseVar | 3,045,401 |
| 8 | EconomicCapitalRatio | -3.64 |
Edgar->Model Mapping
Feature Distribution
Change over Time
